Close Menu

NEW YORK – The US Food and Drug Administration on Monday granted Emergency Use Authorization for Hologic's Panther Fusion SARS-CoV-2 assay, the company announced after the close of the market.

The FDA also issued EUA to Laboratory Corporation of America's coronavirus assay, as the total number of emergency-use-authorized commercial assays for detecting SARS-CoV-2, which causes COVID-19, grew to four, in addition to EUA-designated tests from the US Centers for Disease Control and Prevention and the New York State Department of Health.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.